MDM2 and breast carcinoma: Several mechanisms have been described; in breast cancer cells, the Mdm2 inhibitor p14ARF is downregulated 133, and activated Akt phosphorylates and stabilizes Mdm2 in colorectal HCT116 p53 (+/+) cells 89.